Cordyceps Sunshine Biotech Holdings (RAJAF) Total Non-Current Liabilities (2022 - 2025)

Cordyceps Sunshine Biotech Holdings' Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $5.0 million for Q4 2025.

• In Q4 2025, Total Non-Current Liabilities rose 1.08% year-over-year to $5.0 million; the TTM figure through Dec 2025 stood at $5.0 million (up 1.08% YoY), while the FY2025 annual figure was $5.0 million, up 1.08% from the prior year.
• Total Non-Current Liabilities was $5.0 million for Q4 2025 at Cordyceps Sunshine Biotech Holdings, up from $4.9 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $5.0 million in Q4 2025 to a low of $1.7 million in Q4 2022.
• Historically, Total Non-Current Liabilities has averaged $3.7 million across 4 years, with a median of $4.2 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities soared 107.66% in 2023, then increased 1.08% in 2025.
• A 4-year view of Total Non-Current Liabilities shows it stood at $1.7 million in 2022, then soared by 107.66% to $3.5 million in 2023, then soared by 41.3% to $4.9 million in 2024, then gained by 1.08% to $5.0 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $5.0 million (Q4 2025), $4.9 million (Q4 2024), and $3.5 million (Q4 2023), per Business Quant data.